It doesn't hasten girls' entrance into adulthood or turn them into sex maniacs. It protects from cancer.
One of life's hardest lessons is learned early on. Or at least it should be. As J.M. Barrie immortalized in the opening sentences of Peter Pan:
All children, except one, grow up. They soon know that they will grow up, and the way Wendy knew was this. One day when she was two years old she was playing in a garden, and she plucked another flower and ran with it to her mother. I suppose she must have looked rather delightful, for Mrs Darling put her hand to her heart and cried, "Oh, why can't you remain like this for ever!" This was all that passed between them on the subject, but henceforth Wendy knew that she must grow up.
Profound a truth as this may be, there must be remain some who insist on trying their hardest to unlearn it. Why else would Pediatrics deem it necessary to publish a study, as it did today, establishing that the HPV vaccine does not somehow cause adolescent girls to become prematurely promiscuous? That time and money had to be spent proving this -- and that the results are being so widely touted -- is in deference to the delusional: the Mrs. Darlings attempting to convince themselves that their Wendys can, in perpetuity, remain untouched.
They do so at their daughters' risk.
HPV poses a threat as both the most common sexually transmitted disease in the U.S. -- the CDC reports that most sexually active adults will contract the virus at some point in their lives -- and as a leading cause of cervical cancer, which affects 12,000 U.S. women each year and kills one-third of them.
But as of 2011, the CDC reported in August, only 34.8 percent of girls aged 13 to 17 had received all three doses of the shot proven to protect against HPV, a tip-toe forward from the 32 percent who were immunized in 2010.
That the vaccine associates adolescent girls with sexual activity is widely acknowledged to be one of the reasons why it has yet to catch on. When Yale modeled public compliance with the vaccination recommendations, it found that the biggest obstacle was "the dramatic perception that sexual risk among adolescent vaccine recipients would nearly double."
Today's study, sponsored by the Kaiser Permanente Center for Health Research and Emory University, indicates that despite this association, vaccination does not encourage young women to initiate sexual activity at an earlier age.
A study from January established the same thing in slightly older girls. Although it relied on self-reporting, the new study is more difficult to dispute. Instead of asking the young girls outright if they were engaging in sexual activity, it looked for indirect signs that such activity might be going on: Were they seeking birth control advice? Had they been tested for STDs or pregnancy?
The overwhelming majority had not. These are girls, almost 500 of them, who got the shot at the recommended age of 11 or 12, and as the authors point out, only about 3 percent of high school girls report having become sexually active before the age of 13. Within three years of follow-up, the girls who did seek out birth control or get tested for pregnancy/STDs did not do so any more than their 900 peers who had not been vaccinated.